Interacting Drugs |
Methylphenidate vs Anti-Parkinson's Agents (Dopamine Agonist) |
Security Level |
|
Mechanism |
Anti-Parkinson's Agents (Dopamine Agonist): Methylphenidate may enhance the adverse/toxic effect of Anti-Parkinson's Agents (Dopamine Agonist). |
Management |
Monitor therapy |
Methylphenidate vs Anti-Parkinson’s Agents (Dopamine Agonist)
Post Review about Methylphenidate vs Anti-Parkinson’s Agents (Dopamine Agonist) Click here to cancel reply.
Other Interactions of Methylphenidate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.